Medicus Pharma regains compliance with Nasdaq minimum bid price requirement
MDCX•Medicus Pharma regained compliance with Nasdaq’s $1 minimum bid price requirement on October 23, 2026, after its shares closed at or above $1 for 10 consecutive business days.
1. Compliance restored
Medicus Pharma said Nasdaq notified it that it had regained compliance with the $1 minimum bid price requirement on October 23, 2026. Its shares closed at or above $1 for 10 consecutive business days, from October 12 through October 23. The notice superseded Nasdaq’s October 20 determination to delist the company’s common shares and warrants.
